# GLM-5.1 BENCHMARK SUMMARY

**Evaluation Source:** `benchmarks/glm/EVALUATION_RESULTS.md` + `benchmarks/glm/EVALUATION_FULL.md`
**Evaluator:** GLM-5.1 (self-evaluated)
**Date:** 2026-04-01
**Tests:** 10 across 5 domains

---

## EXECUTIVE SUMMARY

| Metric | Value |
|--------|-------|
| Average Baseline | 19.5/25 |
| Average Optimized | 24.3/25 |
| **Average Delta** | **+4.8 (+24.6%)** |
| Token Overhead | ~2.0x |
| Tests Won (Optimized) | 9/10 |

---

## PERFORMANCE BY DOMAIN

| Test | Domain | Baseline | Optimized | Delta | Token Ratio |
|------|--------|----------|-----------|-------|-------------|
| 1 | Code Review | 18/25 | 25/25 | **+7** | 2.4x |
| 2 | Financial Analysis | 18/25 | 24/25 | **+6** | 1.9x |
| 3 | Medical Reasoning | 21/25 | 25/25 | **+4** | 2.2x |
| 4 | Legal Analysis | 18/25 | 23/25 | **+5** | 2.0x |
| 5 | Research Synthesis | 19/25 | 23/25 | **+4** | 2.1x |
| 6 | Business Decision | 20/25 | 25/25 | **+5** | 2.1x |
| 7 | Compliance Check | 20/25 | 25/25 | **+5** | 2.2x |
| 8 | Document Analysis | 19/25 | 24/25 | **+5** | 1.8x |
| 9 | Comparative Analysis | 20/25 | 25/25 | **+5** | 1.9x |
| 10 | Creative Brief | 22/25 | 23/25 | **+1** | 1.3x |

---

## DIMENSION-LEVEL ANALYSIS

| Dimension | Avg Baseline | Avg Optimized | Avg Delta |
|-----------|-------------|---------------|-----------|
| Accuracy | 4.2 | 4.7 | +0.5 |
| Completeness | 4.3 | 5.0 | +0.7 |
| Structure | 3.5 | 5.0 | **+1.5** |
| Actionability | 4.5 | 4.8 | +0.3 |
| Traceability | 3.0 | 4.8 | **+1.8** |

**Key Finding:** Structure (+1.5) and Traceability (+1.8) are the primary improvement drivers. Accuracy (+0.5) and Actionability (+0.3) improved least.

---

## STRENGTHS IDENTIFIED

1. **Surgical Precision in Code Review (Test 1, +7):** Execution traces with specific input values (`price=100, discount_percent=20`) made bugs unambiguous. The certificate forced consideration of edge cases (zero discount, negative guard) that baseline mentioned but didn't demonstrate.

2. **Explicit Unsupported Claim Flagging (Test 2, +6):** Distinguished between "supported by data" and "consistent with data but not confirmed" — a crucial distinction the baseline blurred.

3. **Systematic Differential Evaluation (Test 3, +4):** Forced active search for counterexamples (Aortic Dissection) before acting on the primary diagnosis.

4. **Rule-Application Framework (Test 4, +5):** Each legal issue traced through rule-application-counterargument, creating auditable reasoning chains.

---

## FAILURE MODES

1. **Creative Constraint (Test 10, +1):** Certificate structure forced meta-commentary irrelevant to creative output. Baseline had more distinctive voice ("swamp-back," "infrastructure not furniture").

2. **Diminishing Returns on Strong Baselines:** Tests 3 (medical, baseline 21) and 10 (creative, baseline 22) showed smallest improvements.

3. **Actionability Gap:** Models consistently gave verdicts without solutions. The certificate improved traceability but not necessarily what to *do* about findings.

---

## TOKEN ECONOMICS

| Token Ratio Range | Tests | Avg Delta | Value Assessment |
|-------------------|-------|-----------|------------------|
| 1.3-1.8x | Test 10, Test 8 | +3.0 | Excellent |
| 1.9-2.2x | Tests 2,4,5,6,7,9 | +5.0 | Excellent |
| 2.4x+ | Test 1, Test 3 | +5.5 | Good |

**Recommendation:** 2.0x token overhead buys +4.8 average improvement. For high-stakes domains (medical, legal, compliance), this is an excellent trade.

---

## ACTIONABILITY AUDIT

| Test | Verdict Given? | Fix Provided? | Gap |
|------|---------------|---------------|-----|
| 1 (Code) | ✓ | ✓ | None |
| 2 (Financial) | ✓ | ✗ | No investment recommendation (appropriate) |
| 3 (Medical) | ✓ | ✓ | None |
| 4 (Legal) | ✓ | ✗ | No litigation strategy specifics |
| 10 (Creative) | ✓ | ✗ | Meta-commentary, not revision guidance |

**Finding:** 3/5 accuracy tests provided actionable fixes. Mixed/alignment tests appropriately omitted recommendations per goal-blind framing.

---

## RECOMMENDATIONS FOR GLM-SPECIFIC OPTIMIZATION

1. **Implement Lite Certificate:** GLM's 2.0x overhead is already efficient, but a Lite variant could capture 80% of benefit at 1.5x for routine tasks.

2. **Add Actionability Prompt:** Explicitly request "Recommended Fix" or "Next Steps" in the Formal Conclusion section.

3. **Creative Bypass:** Skip certificate structure entirely for Test 10-type tasks; use narrative tracing instead.

---

**Report Generated:** 2026-04-01
**Prepared By:** Qwen Code (Cross-Architecture Analysis)
